Knowing therapy development is a challenging process, NINDS asked its biologic consultant contractors to generate guidance documents to better prepare investigators.
Screening services, molecular targeting, drug development services
ResearchMatch is a free, secure registry, making it easier for the public to volunteer and to become involved in clinical research studies that contribute to improved human health. The tool is expected to reduce recruitment costs, increase enrollment and speed …
REDCap is an easy-to-use, freely available tool for clinical study management and data capture, providing investigators with the ability to build and manage online surveys and databases.
Offers well-established, broadly validated measures of phenotypic traits and environmental exposures of interest to investigators in human genomics, epidemiology and biomedical research.
Public website developed by NIH’s National Institute of Allergy and Infectious Diseases to help researchers navigate country-specific regulatory information as they plan and implement clinical trials.
Online glossary developed by a Food and Drug Administration and NIH joint committee to clarify terms used in translational science and medical product development, with a focus on study endpoints and biomarkers.
A standardized contract model designed to reduce negotiation time and contracting delays for industry-sponsored multi-site clinical studies, including Phase IIb and Phase III trials.
Training workshops designed to share best practices and advice on robust assay design, development and implementation for researchers involved in the drug discovery process.
The Assay Guidance Manual initiative delivers resources on best practices within the early stages of development as well as training focusing on robust, early-stage drug discovery assays.
The BrIDGs program assists researchers in advancing promising therapeutic agents through late-stage pre-clinical development toward an Investigational New Drug (IND) application and clinical testing.
TRND program supports pre-clinical development of therapeutic candidates intended to treat rare or neglected disorders, with the goal of enabling an Investigational New Drug (IND) application.